Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Characterization and mechanism of lead and zinc biosorption by growing Verticillium insectorum J3.

Feng CL, Li J, Li X, Li KL, Luo K, Liao XS, Liu T.

PLoS One. 2018 Dec 4;13(12):e0203859. doi: 10.1371/journal.pone.0203859. eCollection 2018.

2.

Involvement of X-chromosome Reactivation in Augmenting Cancer Testis Antigens Expression: A Hypothesis.

Liu C, Luo B, Xie XX, Liao XS, Fu J, Ge YY, Li XS, Guo GS, Shen N, Xiao SW, Zhang QM.

Curr Med Sci. 2018 Feb;38(1):19-25. doi: 10.1007/s11596-018-1842-0. Epub 2018 Mar 15.

PMID:
30074147
3.

Ultrasound-Guided Percutaneous Needle Biopsy for Peripheral Pulmonary Lesions: Diagnostic Accuracy and Influencing Factors.

Guo YQ, Liao XH, Li ZX, Chen YY, Wang SD, Wang JH, Liao XS, Luo Y.

Ultrasound Med Biol. 2018 May;44(5):1003-1011. doi: 10.1016/j.ultrasmedbio.2018.01.016. Epub 2018 Mar 8.

4.

Nonmissile Penetrating Head Injuries: Surgical Management and Review of the Literature.

Li XS, Yan J, Liu C, Luo Y, Liao XS, Yu L, Xiao SW.

World Neurosurg. 2017 Feb;98:873.e9-873.e25. doi: 10.1016/j.wneu.2016.11.125. Epub 2016 Dec 5. Review.

5.

Effect of Calcium Ions on Dewaterability of Enzymatic-Enhanced Anaerobic Digestion Sludge.

Luo K, Yang Q, Li XM, Zhang SY, Pang Y, Li X, Liao XS.

Appl Biochem Biotechnol. 2015 Aug;176(8):2346-57. doi: 10.1007/s12010-015-1722-z. Epub 2015 Jul 1.

PMID:
26129703
6.
7.

Lymphokine Activated Killer (LAK) Cells Inhibit the in vitro Growth of Myeloid and Erythroid Progenitor Cells Via the Release of Tumor Necrosis Factor-Alphadagger.

Bellone G, Fierro MT, Liao XS, Tos AG, Bonferroni M, Pegoraro L, Foa R.

Leuk Lymphoma. 1990;1(5-6):341-52. doi: 10.1080/10428199009169604.

PMID:
20394563
8.

Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cells.

Lista P, Fierro MT, Liao XS, Bonferroni M, Brizzi MF, Porcu P, Pegoraro L, Foa R.

Eur J Haematol. 1989 May;42(5):425-30.

PMID:
2786477
9.
10.

Lymphokine activated killer (LAK) activity in lymphoproliferative disorders.

Foa R, Fierro MT, Raspadori D, Bonferroni M, Cardona S, Liao XS, Cesano A, Matera L, Gillio Tos A, Tola E, et al.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:153-5. Review.

PMID:
2653494
11.

In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity.

Fierro MT, Liao XS, Lusso P, Bonferroni M, Matera L, Cesano A, Lista P, Arione R, Forni G, Foa R.

Leukemia. 1988 Jan;2(1):50-4.

PMID:
3257539

Supplemental Content

Support Center